| Murugesan Manivasagam, CRNP | |
|
500 Upper Chesapeake Dr, Bel Air, MD 21014-4324 | |
| (443) 643-1500 | |
| (443) 643-1505 |
| Full Name | Murugesan Manivasagam |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 500 Upper Chesapeake Dr, Bel Air, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932670122 | NPI | - | NPPES |
| Entity Name | Emergency Medicine Associates Pa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20040126000955 |
News Archive
Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."
PharmaTrust has been invited to participate in the Private Company forum of the Goldman Sachs 31st Annual Healthcare Conference in Los Angeles, June 14th to 17th. The company will demonstrate its revolutionary Healthcare…Everywhere MedCenter which will connect conference 'patients' in Los Angeles to PharmaTrust pharmacists in Toronto.
In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson's disease. The outcomes proved for the first time that transplanted nerve cells can survive and function in the diseased human brain. Some patients showed marked improvement after the transplantation while others showed moderate or no relief of symptoms.
On Saturday, investigators presented positive safety and cognitive efficacy data for ANAVEX 2-73, the Company's lead investigational oral treatment for Alzheimer's disease targeting sigma-1 and muscarinic receptors, which are believed to reduce protein misfolding including reduction of beta amyloid, tau protein and inflammation at the international CTAD 2015 conference in Barcelona, Spain.
An updated practical resource guide for internists on the health care reform law adopted last March 23, the Patient Protection and Affordable Care Act (PPACA), was released today by the American College of Physicians (ACP).
› Verified 8 days ago
| Entity Name | Greater Baltimore Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891855763 PECOS PAC ID: 1759276975 Enrollment ID: O20040217000852 |
News Archive
Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."
PharmaTrust has been invited to participate in the Private Company forum of the Goldman Sachs 31st Annual Healthcare Conference in Los Angeles, June 14th to 17th. The company will demonstrate its revolutionary Healthcare…Everywhere MedCenter which will connect conference 'patients' in Los Angeles to PharmaTrust pharmacists in Toronto.
In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson's disease. The outcomes proved for the first time that transplanted nerve cells can survive and function in the diseased human brain. Some patients showed marked improvement after the transplantation while others showed moderate or no relief of symptoms.
On Saturday, investigators presented positive safety and cognitive efficacy data for ANAVEX 2-73, the Company's lead investigational oral treatment for Alzheimer's disease targeting sigma-1 and muscarinic receptors, which are believed to reduce protein misfolding including reduction of beta amyloid, tau protein and inflammation at the international CTAD 2015 conference in Barcelona, Spain.
An updated practical resource guide for internists on the health care reform law adopted last March 23, the Patient Protection and Affordable Care Act (PPACA), was released today by the American College of Physicians (ACP).
› Verified 8 days ago
| Entity Name | Upper Chesapeake Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497801419 PECOS PAC ID: 3173556974 Enrollment ID: O20050913000525 |
News Archive
Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."
PharmaTrust has been invited to participate in the Private Company forum of the Goldman Sachs 31st Annual Healthcare Conference in Los Angeles, June 14th to 17th. The company will demonstrate its revolutionary Healthcare…Everywhere MedCenter which will connect conference 'patients' in Los Angeles to PharmaTrust pharmacists in Toronto.
In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson's disease. The outcomes proved for the first time that transplanted nerve cells can survive and function in the diseased human brain. Some patients showed marked improvement after the transplantation while others showed moderate or no relief of symptoms.
On Saturday, investigators presented positive safety and cognitive efficacy data for ANAVEX 2-73, the Company's lead investigational oral treatment for Alzheimer's disease targeting sigma-1 and muscarinic receptors, which are believed to reduce protein misfolding including reduction of beta amyloid, tau protein and inflammation at the international CTAD 2015 conference in Barcelona, Spain.
An updated practical resource guide for internists on the health care reform law adopted last March 23, the Patient Protection and Affordable Care Act (PPACA), was released today by the American College of Physicians (ACP).
› Verified 8 days ago
| Entity Name | Hospitalist Medicine Physicians Of Maryland Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992945471 PECOS PAC ID: 8729138003 Enrollment ID: O20120223000194 |
News Archive
Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."
PharmaTrust has been invited to participate in the Private Company forum of the Goldman Sachs 31st Annual Healthcare Conference in Los Angeles, June 14th to 17th. The company will demonstrate its revolutionary Healthcare…Everywhere MedCenter which will connect conference 'patients' in Los Angeles to PharmaTrust pharmacists in Toronto.
In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson's disease. The outcomes proved for the first time that transplanted nerve cells can survive and function in the diseased human brain. Some patients showed marked improvement after the transplantation while others showed moderate or no relief of symptoms.
On Saturday, investigators presented positive safety and cognitive efficacy data for ANAVEX 2-73, the Company's lead investigational oral treatment for Alzheimer's disease targeting sigma-1 and muscarinic receptors, which are believed to reduce protein misfolding including reduction of beta amyloid, tau protein and inflammation at the international CTAD 2015 conference in Barcelona, Spain.
An updated practical resource guide for internists on the health care reform law adopted last March 23, the Patient Protection and Affordable Care Act (PPACA), was released today by the American College of Physicians (ACP).
› Verified 8 days ago
| Entity Name | University Of Maryland St Joseph Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770836785 PECOS PAC ID: 4880846179 Enrollment ID: O20121213000234 |
News Archive
Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."
PharmaTrust has been invited to participate in the Private Company forum of the Goldman Sachs 31st Annual Healthcare Conference in Los Angeles, June 14th to 17th. The company will demonstrate its revolutionary Healthcare…Everywhere MedCenter which will connect conference 'patients' in Los Angeles to PharmaTrust pharmacists in Toronto.
In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson's disease. The outcomes proved for the first time that transplanted nerve cells can survive and function in the diseased human brain. Some patients showed marked improvement after the transplantation while others showed moderate or no relief of symptoms.
On Saturday, investigators presented positive safety and cognitive efficacy data for ANAVEX 2-73, the Company's lead investigational oral treatment for Alzheimer's disease targeting sigma-1 and muscarinic receptors, which are believed to reduce protein misfolding including reduction of beta amyloid, tau protein and inflammation at the international CTAD 2015 conference in Barcelona, Spain.
An updated practical resource guide for internists on the health care reform law adopted last March 23, the Patient Protection and Affordable Care Act (PPACA), was released today by the American College of Physicians (ACP).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Murugesan Manivasagam, CRNP 2720 Sunnyside Ln, Ellicott City, MD 21043-3686 Ph: () - | Murugesan Manivasagam, CRNP 500 Upper Chesapeake Dr, Bel Air, MD 21014-4324 Ph: (443) 643-1500 |
News Archive
Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."
PharmaTrust has been invited to participate in the Private Company forum of the Goldman Sachs 31st Annual Healthcare Conference in Los Angeles, June 14th to 17th. The company will demonstrate its revolutionary Healthcare…Everywhere MedCenter which will connect conference 'patients' in Los Angeles to PharmaTrust pharmacists in Toronto.
In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson's disease. The outcomes proved for the first time that transplanted nerve cells can survive and function in the diseased human brain. Some patients showed marked improvement after the transplantation while others showed moderate or no relief of symptoms.
On Saturday, investigators presented positive safety and cognitive efficacy data for ANAVEX 2-73, the Company's lead investigational oral treatment for Alzheimer's disease targeting sigma-1 and muscarinic receptors, which are believed to reduce protein misfolding including reduction of beta amyloid, tau protein and inflammation at the international CTAD 2015 conference in Barcelona, Spain.
An updated practical resource guide for internists on the health care reform law adopted last March 23, the Patient Protection and Affordable Care Act (PPACA), was released today by the American College of Physicians (ACP).
› Verified 8 days ago